Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration
ContributorsLauper, Kim
; Nordström, Dan C; Pavelka, Karel; Hernández, Maria Victoria; Kvien, Tore K; Kristianslund, Eirik Klami; Santos, Maria Jose; Rotar, Žiga; Iannone, Florenzo; Codreanu, Catalin; Lukina, Galina; Gale, Sara L; Sarsour, Khaled; Luder, Yves; Courvoisier, Delphine Sophie; Gabay, Cem
Published inAnnals of the Rheumatic Diseases, vol. 77, no. 9, p. 1276-1282
Publication date2018
Abstract
Affiliation entities
Citation (ISO format)
LAUPER, Kim et al. Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. In: Annals of the Rheumatic Diseases, 2018, vol. 77, n° 9, p. 1276–1282. doi: 10.1136/annrheumdis-2017-212845
Main files (1)
Article (Published version)
Identifiers
- PID : unige:111916
- DOI : 10.1136/annrheumdis-2017-212845
- PMID : 29730637
Journal ISSN0003-4967
